Old world cutaneous leishmaniasis (CL) is caused by Leishmania major and Leishmania tropica, and is endemic to several Asian and Middle-Eastern countries where the rates of infection can be substantial. CL is one of the most common vector-transmitted parasitic infections in Afghanistan. Six cases of CL in Canadian soldiers returning from Afghanistan are reported in the present study. Their lesions did not improve with fluconazole therapy, and the organism demonstrated in vitro resistance. Oral miltefosine seemed effective.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2663468 | PMC |
| http://dx.doi.org/10.1155/2008/802710 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Discovery of a Series of Macrocycles as Potent Inhibitors of .
J Med Chem
October 2024
Department of Chemistry - BMC, Uppsala University, 751 23 Uppsala, Sweden.
Article Synopsis
- Macrocycles, derived from natural products, are important in fighting infectious diseases, particularly malaria and certain tropical parasites.
- Researchers discovered new macrocycles related to hymenocardine that effectively inhibit the growth of these parasites, some being more potent than the existing oral drug miltefosine for visceral leishmaniasis.
- While these new compounds show good cell permeability and potential for oral use, challenges remain regarding their low solubility and metabolic stability, suggesting further optimization is needed to enhance their effectiveness.
Development and deployment of a solid oral amphotericin B dosage form to treat visceral leishmaniasis within a pediatric population.
PLoS Negl Trop Dis
September 2024
Department of Urologic Sciences, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Visceral leishmaniasis (VL) is a severe and potentially fatal infection, with over 90% of reported cases occurring in East African countries including Chad, Djibouti, Eritrea, Ethiopia, Kenya, Somalia, South Sudan, Sudan, and Uganda, affecting mainly impoverished individuals, and creating a significant economic burden. Currently, the intravenous single-dose liposomal amphotericin B is the first choice for the treatment of VL. Recently, WHO and DNDi have suggested a combination of intravenous liposomal amphotericin B and oral miltefosine as a potential approach to treat VL.
View Article and Find Full Text PDFInvestigational new drugs for the treatment of leishmaniasis.
Expert Opin Investig Drugs
October 2024
Centre of Experimental Medicine and Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.
Introduction: Over the past 20 years, significant progress has been made in anti-leishmanial therapy. Three new drugs/formulations are available for the treatment of various forms of leishmaniasis, namely oral miltefosine, paromomycin and liposomal amphotericin B. However, these advances in drug development have added considerable complexity for clinicians including toxicity, emergence of resistance and decreased sensitivity of available drugs.
View Article and Find Full Text PDFA case of adnexal cutaneous leishmaniasis in Washington DC.
J Ophthalmic Inflamm Infect
August 2024
Department of Ophthalmology, George Washington University School of Medicine, 2150 Pennsylvania Avenue Suite 2A, Washington, DC, USA.
Purpose: To report a rare non-endemic case of Leishmania aethiopica in Washington DC.
Case Report: A 68-year-old female presented for a routine examination with a complaint of right upper eyelid lesions for the past 5 months. On examination, a cluster of elevated and erythematous lesions extending from the medial canthus to the brow area of the right eye were seen.
Cost-effectiveness study of therapeutic approaches for mucosal leishmaniasis.
Cad Saude Publica
August 2024
Instituto René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, Brasil.
This study aimed to estimate the cost-effectiveness of four therapeutic approaches available for mucosal leishmaniasis in Brazil: miltefosine, meglumine antimoniate, combined with and without pentoxifylline, and liposomal amphotericin B. The perspective adopted was that of the Brazilian Unified National Health System (SUS). The outcome of interest was "cured patient", which was analyzed using a decision tree model.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!